About ObsEva
ObsEva is a company based in Geneve (Switzerland) founded in 2012.. ObsEva has raised $94.7 million across 6 funding rounds from investors including Merck, New Leaf Venture Partners and Orbimed. ObsEva operates in a competitive market with competitors including Sprout Pharmaceuticals, Hope Medicine, Rejoni, Gameto and Forendo Pharma, among others.
- Headquarter Geneve, Switzerland
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Obseva Sa
-
Annual Revenue
$19.64 M-12as on Dec 31, 2022
-
Net Profit
$-29.88 M44as on Dec 31, 2022
-
EBITDA
$-15.68 M72as on Dec 31, 2022
-
Total Equity Funding
$94.7 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Merck
& 15 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of ObsEva
ObsEva has successfully raised a total of $94.7M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(29 Aug 2013)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Post-IPO - ObsEva | Valuation |
investors |
|
| Aug, 2019 | Amount | Debt – Conventional - ObsEva | Valuation |
investors |
|
| Oct, 2017 | Amount | Post-IPO - ObsEva | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ObsEva
ObsEva has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, New Leaf Venture Partners and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life sciences are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ObsEva
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ObsEva
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Obseva Comparisons
Competitors of ObsEva
ObsEva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, Hope Medicine, Rejoni, Gameto and Forendo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Therapeutics for fertility and menopause treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for reproductive health are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Obseva
Frequently Asked Questions about ObsEva
When was ObsEva founded?
ObsEva was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is ObsEva located?
ObsEva is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Is ObsEva a funded company?
ObsEva is a funded company, having raised a total of $94.7M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $60M, raised on Aug 29, 2013.
What is the annual revenue of ObsEva?
Annual revenue of ObsEva is $19.64M as on Dec 31, 2022.
What does ObsEva do?
Developer of therapeutics for womens reproductive health and pregnancy. Its lead candidate is Linzagolix an orally active gonadotropin-releasing hormone and receptor antagonist for Fibroids and Endometriosis. It also has two receptor antagonists Ebopiprant and Nolasiban for preterm labor.
Who are the top competitors of ObsEva?
ObsEva's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Who are ObsEva's investors?
ObsEva has 16 investors. Key investors include Merck, New Leaf Venture Partners, Orbimed, Oxford Finance, and HBM Healthcare Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.